SMAD5 and diffuse large B-cell lymphoma: In diffuse large B-cell lymphoma (DLBCL), the evidence shows that cell proliferation is impeded by direct binding of lncRNA SMAD5-AS1 to miR-135b-5p, resulting in the increased expression of APC and the decreased activation of the Wnt/Beta-catenin pathway [14].